Ulf Rosén joined the Board of Directors at TFS International in 2006.
Ulf is General Partner of Danish VC firm SEED Capital where he is responsible for the Medtech/Digital health investments of the Group. He is Chairman, Board Member and Founder of several companies based in Scandinavia - Chairman of LobSor Holding/LobSor Pharmaceutical and Board Member of Reapplix ApS, Acarix A/S, Curasight A/S and MagCath ApS. His previous operational positions include: President & CEO of NeoPharma AB; General Manager of Fresenius-Kabi (Sweden & UK); Executive Vice President Global Nutrition Division at Fresenius-Kabi; and, President & CEO of Pharmacia & Upjohn (Norway). In addition, he has held Chairman and Board Memberships with several life science companies including Connect Uppsala and the Swedish Trade Association.